BioCentury | Feb 28, 2020
Finance

Verastem raises $100M, plots path forward with targeted cancer combo

...γ PI3Kδ - Phosphoinositide 3-kinase δ Paul Bonanos, Associate Editor Copiktra, duvelisib (IPI-145, ink-1197) Verastem Inc. Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma MEK Focal...
BioCentury | Jun 18, 2019
Clinical News

June 17 Clinical Quick Takes: VBI's HBV vaccine misses secondary endpoint, plus ArQule, Verastem and more

...Inc. BioNTech SE Calithera Biosciences Inc. VBI Vaccines Inc. Verastem Inc. Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1) Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma Programmed...
BioCentury | Sep 28, 2018
Company News

Verastem grants CSPC rights to Copiktra in China

...Group Ltd. (HKSE:1093), Hong Kong, China Business: Cancer Meghan Sullivan Duvelisib CSPC Pharmaceutical Group Ltd. Verastem Inc. Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma Copiktra...
BioCentury | Sep 28, 2018
Clinical News

FDA approves Verastem's duvelisib

...Inc. (NASDAQ:VSTM), Needham, Mass. Product: Copiktra duvelisib Business: Cancer Jennie Walters Duvelisib (IPI-145, ink-1197) Verastem Inc. Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma Copiktra...
BioCentury | Sep 25, 2018
Company News

Verastem grants CSPC rights to Copiktra in China

...after-hours trading. CSPC was off HK$0.52 to HK$16.66. Meghan Sullivan Duvelisib CSPC Pharmaceutical Group Ltd. Verastem Inc. Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma Copiktra...
BioCentury | Sep 24, 2018
Company News

FDA approves Verastem's duvelisib

...Verastem gained $0.24 to $8.89 on Monday. Jennie Walters Duvelisib (IPI-145, ink-1197) Verastem Inc. Phosphoinositide 3-kinase (PI3K) Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma...
BioCentury | Jun 28, 2018
Distillery Therapeutics

Cancer

...Academy of Medical Sciences Peking Union Medical College Phosphoinositide 3-kinase (PI3K) alpha Phosphoinositide 3-kinase (PI3K) beta Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma...
BioCentury | Jun 21, 2018
Product R&D

Tusk’s take on CD25

...factor (GM-CSF; CSF2) IL-2 - Interleukin-2 IL2RG (CD132) - Interleukin-2 receptor γ chain PI3Kγ - Phosphoinositide 3-kinase (PI3K) gamma...
BioCentury | Jun 1, 2018
Clinical News

Infinity reports Phase I data for IPI-549 plus Opdivo in solid tumors

...patients and is also evaluating IPI-549 as monotherapy. IPI-549 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) gamma...
...Cambridge, Mass. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: IPI-549 Business: Cancer Molecular target: Phosphoinositide 3-kinase (PI3K) gamma...
...#), nivolumab (Generic), Opdivo (Other) American Society of Clinical Oncology ASCO Bristol-Myers Squibb Co. Infinity Pharmaceuticals Inc. Takeda Pharmaceutical Co. Ltd. Phosphoinositide 3-kinase (PI3K) gamma Programmed...
BioCentury | Apr 9, 2018
Company News

Verastem gains on duvelisib Priority Review

...oral inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. Mary Romeo Arzerra Duvelisib IPI-145 ofatumumab AbbVie Inc. Infinity Pharmaceuticals Inc. Verastem Inc. Phosphoinositide 3-kinase (PI3K) delta Phosphoinositide 3-kinase (PI3K) gamma...
Items per page:
1 - 10 of 38